PMID: 38658May 1, 1979

Efficacy of ketotifen in bronchial asthma

Allergologia et immunopathologia
S BenosN Kalatzi


Ketotifen was administered orally during a period of three months to 30 patients suffering from bronchial asthma. It proved to be a strong antiasthmatic agent and the results obtained were positive, i.e.: Excellent in 21 patients (70%), very good in 3 patients (10%), Good in 1 patient (4%), Poor in 5 patients (16%), The drug was very well tolerated and no signs of drug toxicity were observed. It is concluded that ketotifen is a very effective and safe drug for the prevention of bronchial asthma.

Related Concepts

Mast Cell
Antihistamines, Classical
Anti-Asthmatic Agents
Drug Evaluation
Forced Expiratory Volume Function

Related Feeds


This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.


Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Related Papers

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
C Mylona-KarayanniF Saxoni-Papageorgiou
The Journal of International Medical Research
Z HlouskováZ Hlousek
The Journal of International Medical Research
J Labus, V Hlinka
© 2020 Meta ULC. All rights reserved